ANNA
MACIA ARMENGOL
CON
![Foto de ANNA](/img/nophoto.png)
![Foto de Hospital Universitari de Bellvitge](/img/noimage_org.png)
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaHospital Universitari de Bellvitge -ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2024
-
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review
Cancers, Vol. 16, Núm. 1
-
Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status
Dermatology, Vol. 240, Núm. 1, pp. 164-169
2022
-
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma
Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259
-
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors
British Journal of Cancer
2020
-
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265
2018
-
T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1
Pigment Cell and Melanoma Research, Vol. 31, Núm. 4, pp. 484-495